skip to content
Polymer drugs in the clinical stage : advantages and prospects Preview this item
ClosePreview this item
Checking...

Polymer drugs in the clinical stage : advantages and prospects

Author: H Maeda; Alexander V Kabanov
Publisher: Dordrecht ; London : Kluwer Academic/Plenum, 2003.
Series: Advances in experimental medicine and biology, v. 519.
Edition/Format:   eBook : Document : Conference publication : EnglishView all editions and formats
Database:WorldCat
Summary:
Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Conference papers and proceedings
Congresses
Additional Physical Format: Print version:
Polymer drugs in the clinical stage.
Dordrecht ; London : Kluwer Academic/Plenum, 2003
(DLC) 2003266837
(OCoLC)52349063
Material Type: Conference publication, Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: H Maeda; Alexander V Kabanov
ISBN: 030647932X 9780306479328
OCLC Number: 55620326
Notes: "Proceedings of the International Symposium on Polymer Therapeutics--Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan"--Title page verso.
Description: 1 online resource (viii, 224 pages) : illustrations.
Contents: Challenges in Polymer Therapeutics: State of the Art and Prospects of Polymer Drugs --
Factors and Mechanism of "EPR" Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS --
PEG-Adenosine Deaminase and PEG-Asparaginase --
Peginterferon alfa-2a (40KD): A Potent Long-Acting Form of Interferon alfa-2a for the Treatment of Hepatitis C --
PEG-Methioninase --
Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103)[XYOTAX], a Biodegradable Polymeric Drug Conjugate: Characterization, Preclinical Pharmacology, and Preliminary Clinical Data --
HPMA Copolymer Delivery of Chemotherapy and Photodynamic Therapy in Ovarian Cancer --
Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer --
CM-Dextran-Polyalcohol-Camptothecin Conjugate: DE310 with a Novel Carrier System and its Preclinical Data --
Polymeric Micelle Drug Carrier Systems: PEG-PAsp(Dox) and Second Generation of Micellar Drugs --
An Interim Analysis of Phase I Clinical Trial of MCC-465, a Doxorubicin (DXR) Encapsulated in PEG-immunoliposome, in Patients with Metastatic Stomach Cancer --
Polymer Conjugates for Imaging --
S-Nitrosylated Polyethylene Glycol-conjugated Hemoglobin Derivative as a Candidate Material for Oxygen Therapeutics --
Index.
Series Title: Advances in experimental medicine and biology, v. 519.
Responsibility: edited by Hiroshi Maeda and Alexander Kabanov.

Abstract:

Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes. This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/55620326> # Polymer drugs in the clinical stage : advantages and prospects
    a schema:CreativeWork, schema:MediaObject, schema:Book ;
    library:oclcnum "55620326" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/ne> ;
    library:placeOfPublication <http://dbpedia.org/resource/London> ; # London
    library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/793928212#Place/dordrecht> ; # Dordrecht
    schema:about <http://dewey.info/class/615.1/e22/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/polymers> ; # Polymers
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/medical_pharmacology> ; # MEDICAL--Pharmacology
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/pharmaceutical_preparations> ; # Pharmaceutical preparations
    schema:about <http://id.worldcat.org/fast/1060280> ; # Pharmacology, Experimental
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/medical_pharmacy> ; # MEDICAL--Pharmacy
    schema:about <http://id.loc.gov/authorities/subjects/sh88007108> ; # Drug delivery systems
    schema:about <http://id.worldcat.org/fast/898667> ; # Drug delivery systems
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/drug_delivery_systems> ; # Drug Delivery Systems
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/medical_nursing_pharmacology> ; # MEDICAL--Nursing--Pharmacology
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/drug_carriers> ; # Drug Carriers
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/medical_drug_guides> ; # MEDICAL--Drug Guides
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/polymers_therapeutic_use> ; # Polymers--Therapeutic use
    schema:about <http://id.loc.gov/authorities/subjects/sh85100600> ; # Pharmacology, Experimental
    schema:about <http://experiment.worldcat.org/entity/work/data/793928212#Topic/drugs_investigational> ; # Drugs, Investigational
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/793928212#Meeting/international_symposium_on_polymer_therapeutics_recent_progress_in_clinics_and_future_prospects_2001_nara_japan> ; # International Symposium on Polymer Therapeutics: Recent Progress in Clinics and Future Prospects (2001 : Nara, Japan)
    schema:contributor <http://experiment.worldcat.org/entity/work/data/793928212#Person/maeda_h_hiroshi> ; # Hiroshi Maeda
    schema:contributor <http://viaf.org/viaf/1765060> ; # Alexander V. Kabanov
    schema:datePublished "2003" ;
    schema:description "Challenges in Polymer Therapeutics: State of the Art and Prospects of Polymer Drugs -- Factors and Mechanism of "EPR" Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS -- PEG-Adenosine Deaminase and PEG-Asparaginase -- Peginterferon alfa-2a (40KD): A Potent Long-Acting Form of Interferon alfa-2a for the Treatment of Hepatitis C -- PEG-Methioninase -- Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103)[XYOTAX], a Biodegradable Polymeric Drug Conjugate: Characterization, Preclinical Pharmacology, and Preliminary Clinical Data -- HPMA Copolymer Delivery of Chemotherapy and Photodynamic Therapy in Ovarian Cancer -- Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer -- CM-Dextran-Polyalcohol-Camptothecin Conjugate: DE310 with a Novel Carrier System and its Preclinical Data -- Polymeric Micelle Drug Carrier Systems: PEG-PAsp(Dox) and Second Generation of Micellar Drugs -- An Interim Analysis of Phase I Clinical Trial of MCC-465, a Doxorubicin (DXR) Encapsulated in PEG-immunoliposome, in Patients with Metastatic Stomach Cancer -- Polymer Conjugates for Imaging -- S-Nitrosylated Polyethylene Glycol-conjugated Hemoglobin Derivative as a Candidate Material for Oxygen Therapeutics -- Index."@en ;
    schema:description "Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes. This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/793928212> ;
    schema:genre "Conference papers and proceedings"@en ;
    schema:genre "Conference publication"@en ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/793928212#Series/advances_in_experimental_medicine_and_biology> ; # Advances in experimental medicine and biology ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/52349063> ;
    schema:name "Polymer drugs in the clinical stage : advantages and prospects"@en ;
    schema:productID "55620326" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/55620326#PublicationEvent/dordrecht_london_kluwer_academic_plenum_2003> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/793928212#Agent/kluwer_academic_plenum> ; # Kluwer Academic/Plenum
    schema:url <http://dx.doi.org/10.1007/b105364> ;
    schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=99429> ;
    schema:workExample <http://worldcat.org/isbn/9780306479328> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/55620326> ;
    .


Related Entities

<http://dbpedia.org/resource/London> # London
    a schema:Place ;
    schema:name "London" ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Agent/kluwer_academic_plenum> # Kluwer Academic/Plenum
    a bgn:Agent ;
    schema:name "Kluwer Academic/Plenum" ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Meeting/international_symposium_on_polymer_therapeutics_recent_progress_in_clinics_and_future_prospects_2001_nara_japan> # International Symposium on Polymer Therapeutics: Recent Progress in Clinics and Future Prospects (2001 : Nara, Japan)
    a bgn:Meeting, schema:Event ;
    schema:location <http://experiment.worldcat.org/entity/work/data/793928212#Place/nara_japan> ; # Nara, Japan)
    schema:name "International Symposium on Polymer Therapeutics: Recent Progress in Clinics and Future Prospects (2001 : Nara, Japan)" ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Person/maeda_h_hiroshi> # Hiroshi Maeda
    a schema:Person ;
    schema:familyName "Maeda" ;
    schema:givenName "Hiroshi" ;
    schema:givenName "H." ;
    schema:name "Hiroshi Maeda" ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Series/advances_in_experimental_medicine_and_biology> # Advances in experimental medicine and biology ;
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/55620326> ; # Polymer drugs in the clinical stage : advantages and prospects
    schema:name "Advances in experimental medicine and biology ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Topic/drug_delivery_systems> # Drug Delivery Systems
    a schema:Intangible ;
    schema:name "Drug Delivery Systems"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Topic/drugs_investigational> # Drugs, Investigational
    a schema:Intangible ;
    schema:name "Drugs, Investigational"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Topic/medical_drug_guides> # MEDICAL--Drug Guides
    a schema:Intangible ;
    schema:name "MEDICAL--Drug Guides"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Topic/medical_nursing_pharmacology> # MEDICAL--Nursing--Pharmacology
    a schema:Intangible ;
    schema:name "MEDICAL--Nursing--Pharmacology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Topic/medical_pharmacology> # MEDICAL--Pharmacology
    a schema:Intangible ;
    schema:name "MEDICAL--Pharmacology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Topic/medical_pharmacy> # MEDICAL--Pharmacy
    a schema:Intangible ;
    schema:name "MEDICAL--Pharmacy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Topic/pharmaceutical_preparations> # Pharmaceutical preparations
    a schema:Intangible ;
    schema:name "Pharmaceutical preparations"@en ;
    schema:name "Pharmaceutical Preparations"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/793928212#Topic/polymers_therapeutic_use> # Polymers--Therapeutic use
    a schema:Intangible ;
    schema:name "Polymers--Therapeutic use"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh85100600> # Pharmacology, Experimental
    a schema:Intangible ;
    schema:name "Pharmacology, Experimental"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh88007108> # Drug delivery systems
    a schema:Intangible ;
    schema:name "Drug delivery systems"@en ;
    .

<http://id.worldcat.org/fast/1060280> # Pharmacology, Experimental
    a schema:Intangible ;
    schema:name "Pharmacology, Experimental"@en ;
    .

<http://id.worldcat.org/fast/898667> # Drug delivery systems
    a schema:Intangible ;
    schema:name "Drug delivery systems"@en ;
    .

<http://viaf.org/viaf/1765060> # Alexander V. Kabanov
    a schema:Person ;
    schema:familyName "Kabanov" ;
    schema:givenName "Alexander V." ;
    schema:name "Alexander V. Kabanov" ;
    .

<http://worldcat.org/isbn/9780306479328>
    a schema:ProductModel ;
    schema:isbn "030647932X" ;
    schema:isbn "9780306479328" ;
    .

<http://www.worldcat.org/oclc/52349063>
    a schema:CreativeWork ;
    rdfs:label "Polymer drugs in the clinical stage." ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/55620326> ; # Polymer drugs in the clinical stage : advantages and prospects
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.